-+ 0.00%
-+ 0.00%
-+ 0.00%

Summit Therapeutics releases HARMONi Phase 3 ivonescimab HRQoL presentation; trial enrollment totals 438 patients

Reuters·03/27/2026 16:25:45

Please log in to view news